Welcome to our dedicated page for Nutex Health news (Ticker: NUTX), a resource for investors and traders seeking the latest updates and insights on Nutex Health stock.
Nutex Health Inc. operates as a physician-led healthcare services and operations company with a Hospital Division and a Population Health Management Division. Its hospital operations own, develop and operate micro-hospitals, specialty hospitals and hospital outpatient departments, while the population health business owns provider networks such as independent physician associations and provides management and administrative support through a management services organization.
Company news commonly covers quarterly and annual financial results, hospital openings and reopenings, expansion of facility operations across states, risk-bearing physician network activity, real estate-backed hospital development, earnings calls, healthcare conference participation and common stock repurchase authorizations.
Nutex Health (NASDAQ: NUTX), a physician-led healthcare system with 22 micro hospitals across 10 states, has announced it will release its Q3 2024 financial results after market close on November 7, 2024. The company will host a conference call to discuss the results on November 8, 2024, at 10:30 am ET. Investors can join via phone (1-877-407-9208 or 1-201-493-6784) or webcast. A recording will be available on the company's website for those unable to attend.
Nutex Health Inc. (NASDAQ: NUTX), a physician-led healthcare system with 22 micro hospitals across 10 states, has announced multiple community-driven awards for its hospitals in Q3 2024. These accolades reflect the company's commitment to patient care excellence. Notable awards include:
- Tulsa ER & Hospital: 'Faces of the 918' and 'Face of Emergency Medicine'
- Oklahoma ER & Hospital: 'Faces of Emergency Care'
- Albuquerque ER & Hospital: 'Best Places to Work'
- New Braunfels ER & Hospital: 'Best Emergency Care'
- Cabot Emergency Hospital: Six physicians and CNO named 'Best Healthcare Professionals'
- Tucson ER & Hospital: Multiple 'Favorite' awards including Best Emergency Room and Best Hospital
Additionally, Nutex was named '30 Fastest Growing Companies of the Year 2024' by SME Business Review in August.
Nutex Health (NASDAQ: NUTX) has expanded its healthcare network with the opening of Post Falls ER & Hospital in Idaho. This 25,000 square foot facility, located at 497 S Beck Road, is the company's first hospital in Idaho and serves communities in both Idaho and Washington. The hospital offers:
- 24/7/365 concierge-level care
- 12 ER beds and 5 inpatient beds
- In-house laboratory and pharmacy
- Imaging suite with MRI, CT scan, X-ray, and Ultrasound
Post Falls ER & Hospital aims to provide minimal wait times and ample one-on-one time with board-certified physicians. This marks Nutex Health's second new hospital opening in 2024, following Green Bay ER & Hospital, as part of its ongoing expansion strategy.
Nutex Health (NASDAQ: NUTX) reported strong financial results for Q2 and H1 2024. Total revenue increased 29% to $76.1 million in Q2 and 25% to $143.5 million in H1 compared to 2023. The Hospital Division saw a 28% increase in visits to 41,208 in Q2. Adjusted EBITDA grew 200% to $12.0 million in Q2 and 159% to $16.6 million in H1. Net loss narrowed to $0.4 million in Q2 from $3.5 million in Q2 2023. The company generated $16.3 million in operating cash flow for H1 2024. Nutex Health operates 21 micro hospitals and HOPDs across 9 states, focusing on increasing cash flow and profitability while driving sustainable growth.
Nutex Health Inc. (NASDAQ: NUTX), a physician-led integrated healthcare delivery system, has announced its schedule for releasing 2024 second quarter financial results. The company, which operates 21 micro hospitals across 9 states and manages primary care-centric, risk-bearing physician networks, will disclose its financial performance on Thursday, August 8, 2024, after the stock market closes.
A conference call to discuss these results is scheduled for Friday, August 9, 2024, at 10:00 am ET. Investors and interested parties can participate by dialing 1-877-407-9208 or 1-201-493-6784. Alternatively, a webcast will be available for those who prefer to join online. For those unable to attend the live call, a recording will be accessible on the company's website.
Nutex Health Inc. (NASDAQ: NUTX) has successfully regained compliance with Nasdaq's minimum bid price requirement. This follows the company's 1:10 reverse stock split on July 3, 2024, after which the closing bid price of Nutex Health's common stock remained above $1.00 per share until July 23, 2024. The Nasdaq Stock Market has formally notified Nutex Health of its compliance with Listing Rule 5550(a)(2), considering the previous bid price deficiency matter closed.
Nutex Health operates as a physician-led, technology-enabled integrated healthcare delivery system, comprising 21 state-of-the-art micro hospitals across 9 states and primary care-centric, risk-bearing physician networks. This development ensures the company's continued listing on the Nasdaq Capital Market, as mandated by the Hearing Panel's decision on June 14, 2024.
Nutex Health (NASDAQ: NUTX) announced that its hospitals received nine awards and honors in Q2 2024, highlighting their commitment to patient care excellence. The awards, voted on by local communities, span across multiple facilities:
- Texarkana ER & Hospital won three 'Best Emergency Care' awards and a Distinguished Citizen Honor for their CMO.
- Tulsa ER & Hospital staff received recognition as an 'Influential Woman' and 'Face of Emergency Care'.
- NW Indiana ER & Hospital was named 'Best Hospital' for the fourth consecutive year.
- Royse City Emergency Hospital earned 'Business of the Year' for community impact.
- Albuquerque ER & Hospital was recognized as 'Best Place to Work' for the third year.
These accolades reflect Nutex Health's focus on superior healthcare delivery and patient satisfaction across its 21 micro hospitals in nine states.
Nutex Health announced a 1-for-10 reverse stock split effective July 3, 2024. The reverse split aims to regain compliance with Nasdaq's minimum bid price requirement. Authorized by shareholders on June 17, 2024, the split will reduce common shares from 49 million to 4.9 million but maintain the authorized shares at 950 million. No fractional shares will be issued; instead, shares will be rounded up to the nearest whole number. The split will also proportionately adjust shares reserved for equity compensation and outstanding warrants and stock options.
Nutex Health has received shareholder approval to effect a reverse stock split ranging from 1-for-2 to 1-for-16. This move aims to comply with NASDAQ’s minimum bid price requirement before the July 22, 2024 deadline. The reverse split follows a notice from NASDAQ granting the company an exception to meet the requirement. Nutex Health operates 21 micro hospitals across nine states and integrates healthcare delivery with technology-driven physician networks. Although the reverse stock split is targeted at meeting compliance, the company cannot assure it will achieve the desired market price effects.
On May 24, 2024, Nutex Health (NASDAQ: NUTX) received a Nasdaq staff determination letter indicating non-compliance with the $1.00 bid price requirement, leading to potential delisting. Nutex Health has requested a hearing scheduled for July 9, 2024, to appeal the decision, resulting in a stay of the delisting action. The company is also considering a reverse stock split, pending shareholder approval on June 17, 2024, to meet the minimum bid price requirement. The stock will continue trading on Nasdaq during this period.